[{"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-55745.0,"AccountsPayableRelatedPartiesCurrent_0_Q3_USD":null,"OperatingLeaseExpense_1_Q3_USD":88144.0,"OperatingLeaseExpense_3_Q3_USD":270198.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-1524687.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-7475760.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":132622.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":-28094.0,"ProceedsFromWarrantExercises_3_Q3_USD":1000000.0,"OperatingLeasesFutureMinimumPaymentsDueThereafter_0_Q3_USD":828205.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":338345.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":348495.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":298305.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q3_USD":246004.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q3_USD":82658.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":1867336.0,"NonoperatingIncomeExpense_1_Q3_USD":2315172.0,"NonoperatingIncomeExpense_3_Q3_USD":1772432.0,"Goodwill_0_Q3_USD":11640000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":15154.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q3_USD":30153.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":2006798.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":2006798.0,"PrepaidExpenseCurrent_0_Q3_USD":326378.0,"IncreaseDecreaseInAccountsPayableRelatedParties_3_Q3_USD":-100000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":79403.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":79403.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":82237.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-7318197.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":5000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-1514489.0,"DepreciationDepletionAndAmortization_1_Q3_USD":35764.0,"PropertyPlantAndEquipmentDisposals_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q3_USD":10198.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3_Q3_USD":157563.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.0399,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1769209.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1601155.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":266181.0,"OperatingLeaseLiability_0_Q3_USD":1867336.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":154824000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":-371.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":148936.0,"FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss_3_Q3_USD":2844.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":3788.0,"EquityFairValueAdjustment_3_Q3_USD":-1450202.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":10939166.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":2006798.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-10198.0,"OtherReceivablesNetCurrent_0_Q3_USD":null,"DepositsAssetsNoncurrent_0_Q3_USD":137550.0,"OtherIndefiniteLivedIntangibleAssets_0_Q3_USD":166464000.0,"IncreaseDecreaseInAccountsAndOtherReceivables_3_Q3_USD":-16892.0,"AccountsPayableTradeCurrent_0_Q3_USD":328366.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":-28094.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":895976.0,"InterestIncomeExpenseNet_1_Q3_USD":-12030.0,"InterestIncomeExpenseNet_3_Q3_USD":-12030.0,"IncreaseDecreaseInOperatingLiabilities_3_Q3_USD":-186959.0,"IncreaseDecreaseInOperatingAssets_3_Q3_USD":-192335.0,"LongTermNotesPayable_0_Q3_USD":4506808.0,"DepreciationDepletionAndAmortization_3_Q3_USD":78912.0,"SaleOfStockNumberOfSharesIssuedInTransaction_3_Q3_shares":10000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":140000.0,"InterestAndOtherIncome_1_Q3_USD":12371.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":7200000.0,"LiabilitiesCurrent_0_Q3_USD":971271.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":180509378.0,"Liabilities_0_Q3_USD":10286032.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":130507.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-205197.0,"IncomeTaxExpenseBenefit_1_Q3_USD":null,"IncomeTaxExpenseBenefit_3_Q3_USD":null,"GrossProfit_1_Q3_USD":null,"GrossProfit_3_Q3_USD":null,"GeneralAndAdministrativeExpense_1_Q3_USD":1486561.0,"GeneralAndAdministrativeExpense_3_Q3_USD":5622721.0,"EffectOfExchangeRateOnCashAndCashEquivalents_3_Q3_USD":-154718.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.03,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.16,"Depreciation_1_Q3_USD":35764.0,"Depreciation_3_Q3_USD":78912.0,"CostOfRevenue_1_Q3_USD":null,"CostOfRevenue_3_Q3_USD":null,"CommonStockValue_0_Q3_USD":4650.0,"CommonStockSharesOutstanding_0_Q3_shares":46497409.0,"CommonStockSharesIssued_0_Q3_shares":46497409.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":-1343058.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":10939166.0,"AssetsNoncurrent_0_Q3_USD":168450162.0,"AssetsCurrent_0_Q3_USD":11265544.0,"Assets_0_Q3_USD":180509378.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3554185.0,"AdditionalPaidInCapital_0_Q3_USD":230364478.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-174015.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":920683.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-8214325.0,"NetIncomeLoss_1_Q3_USD":-1514489.0,"InterestAndOtherIncome_3_Q3_USD":45324.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":127011.0,"ShareBasedCompensation_3_Q3_USD":895976.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2307336.0,"ResearchAndDevelopmentExpense_3_Q3_USD":3388996.0,"ProceedsFromNotesPayable_3_Q3_USD":5000000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":1200000.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_1_Q3_USD":-3829661.0,"OperatingIncomeLoss_3_Q3_USD":-9090629.0,"OperatingExpenses_1_Q3_USD":3829661.0,"OperatingExpenses_3_Q3_USD":9090629.0,"DepreciationAndAmortization_3_Q3_USD":78912.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":1200000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q3_USD":376724.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":46275591.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":46280139.0,"StockholdersEquity_0_Q3_USD":170223346.0,"Revenues_1_Q3_USD":null,"Revenues_3_Q3_USD":null,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-60090037.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":793672.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":174015.0,"NetIncomeLoss_3_Q3_USD":-7318197.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q3_shares":0.0,"Ticker":"ENOB","CIK":"1527728","name":"ENOCHIAN BIOSCIENCES INC","OfficialName":"Enochian Biosciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"398960164.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]